| A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer. (NCT05493995) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2022-07-21 |
| Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts (NCT04473794) | Johns Hopkins University | 2022-07-20 |
| Change of Treatment Landscape and Survival in Metastatic Pancreatic Cancer After Nal-IRI in Republic of Korea (NCT05587387) | Yonsei University | 2022-07-01 |
| A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer (NCT05451849) | TCR2 Therapeutics | 2022-06-21 |
| Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary Neoplasms (NCT05225038) | Case Comprehensive Cancer Center | 2022-06-13 |
| Trimodal Prehabilitation in Pancreatic Cancer Patients Urdergoing Neoadjuvant Treatment (NCT05722223) | Puerta de Hierro University Hospital | 2022-03-15 |
| Correlation Between Elastic Modulus of Ultrasonic Shear Wave and Tumor Stromal Component in Pancreatic Cancer (NCT05187416) | Xijing Hospital | 2022-02-01 |
| Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer (NCT04146298) | Changhai Hospital | 2021-10-21 |
| International Pancreatic Surgery Outcomes Study - PancreasGroup.Org (NCT04652271) | Royal Free Hospital NHS Foundation Trust | 2021-09-01 |
| Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic Cancer (NCT05043532) | Orlando Health, Inc. | 2021-08-18 |
| Comparison of Two Types of Biopsy Needles for EUS-FNB in Solid Pancreatobiliary Mass Lesions (NCT04975620) | University of Tehran | 2021-08-01 |
| Circulating Epigenetics in Pancreatic Surgery (NCT04947696) | Rigshospitalet, Denmark | 2021-07-30 |
| Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) (NCT04956640) | Eli Lilly and Company | 2021-07-19 |
| Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer (NCT04327986) | National Cancer Institute (NCI) | 2021-06-15 |
| PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI (NCT05172310) | Karolinska University Hospital | 2021-06-02 |
| LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS) (NCT04889404) | AstraZeneca | 2021-05-22 |
| Spanish Series of Patients Treated With the Radionuclide Lutetium177 (NCT04949282) | Sociedad Española de Medicina Nuclear e Imagen Molecular | 2021-05-10 |
| Prospective Study FNB, Is It Time To Abandon Cytological Assessment (NCT04165018) | Baylor College of Medicine | 2021-04-09 |
| Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic Cancer (NCT04808687) | Tianjin Medical University Cancer Institute and Hospital | 2021-03-01 |
| Discovery of Soluble Biomarkers for Pancreatic Cancer Using Innovative All-Patient Inclusive Methodology (NCT04370574) | University Hospital, Montpellier | 2021-01-14 |
| Evaluation of Prehabilitation as a Strategy to Minimize Surgical Risk in Pancreatic Surgery: Efficacy and Determining Factors. (NCT05489419) | Hospital Clinic of Barcelona | 2021-01-01 |
| Comparsion of WT and SNP Techniques of EUS-FNB in Pancreatic Solid Mass (WESP-PSM) (NCT04605042) | Ruijin Hospital | 2020-12-01 |
| Comparation Between Needles for EUS-guided Sampling of Solid Pancreatic Lesions (NCT04877340) | Instituto do Cancer do Estado de São Paulo | 2020-11-26 |
| Fecal and Oral Microbiota Between Pancreatic Cancer and Benign/Low-grade Malignant Tumor Patients (NCT06659237) | Peking Union Medical College Hospital | 2020-11-01 |
| EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy (NCT04809935) | The University of Hong Kong | 2020-09-21 |
| Pancreatic Anastomosis After Duodenopancreatectomy (NCT04462354) | Fundación para la Investigación del Hospital Clínico de Valencia | 2020-06-04 |
| Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer (NCT04289792) | Fujian Medical University Union Hospital | 2020-05-09 |
| A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer (NCT04137289) | Boehringer Ingelheim | 2020-03-11 |
| Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses (NCT04709445) | Charite University, Berlin, Germany | 2020-03-01 |
| Heparin-based Wet Suction Method in EUS Fine Needle Biopsy of Solid Pancreatic Mass (NCT04707560) | National Cheng-Kung University Hospital | 2020-01-01 |
| Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Surgery (NCT03838029) | Assaf-Harofeh Medical Center | 2019-11-20 |
| A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer (NCT04137536) | Memorial Sloan Kettering Cancer Center | 2019-10-17 |
| UCSF PANC Cyst Registry (NCT04291651) | University of California, San Francisco | 2019-10-08 |
| Fine Needle Biopsy of Solid Pancreatic Mass Lesions (NCT04085055) | AdventHealth | 2019-09-09 |
| Benchmarking Outcomes in Pancreatic Surgery - WhippleBenchmarks.Org (NCT04053998) | Royal Free Hospital NHS Foundation Trust | 2019-08-09 |
| A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001) (NCT03948763) | Merck Sharp & Dohme LLC | 2019-06-26 |
| EUS-FNB With MOSE vs EUS-FNA With ROSE (NCT03766659) | Chinese University of Hong Kong | 2019-06-19 |
| Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer (NCT03977233) | UNC Lineberger Comprehensive Cancer Center | 2019-06-12 |
| Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC (NCT03634332) | Pancreatic Cancer Research Team | 2019-05-01 |
| Monitoring of patIents With Microdialysis Following Pancreaticoduodenectomy (NCT03631173) | Oslo University Hospital | 2019-04-02 |
| Peptide-based Immunization for Colon- and and Pancreas-carcinoma (NCT03871790) | CENTOGENE GmbH Rostock | 2019-04-01 |
| Multivisceral Resection in Distal Pancreatectomy (NCT04317352) | Universidad de Extremadura | 2019-03-01 |
| Magnetic Compressive Anastomosis for Biliojejunostomy and Pancreaticojejunostomy During Whipple's Procedure (NCT03792048) | First Affiliated Hospital Xi'an Jiaotong University | 2019-02-01 |
| The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study (NCT04075305) | UMC Utrecht | 2019-02-01 |
| 9-ING-41 in Patients With Advanced Cancers (NCT03678883) | Actuate Therapeutics Inc. | 2019-01-04 |
| SBRT for Liver Tumors, Liver Metastases, and Pancreatic Tumors (NCT07407257) | Institute of Oncology Ljubljana | 2019-01-01 |
| Greater Omentum Binding to the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy (NCT03752086) | Tongji Hospital | 2019-01-01 |
| A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) (NCT02905578) | University of Iowa | 2018-11-28 |
| Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma (NCT03717298) | Catalysis SL | 2018-10-30 |
| PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors (NCT03685591) | Pfizer | 2018-10-04 |
| A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer (NCT03535727) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-06-21 |
| Hepatic Resection for Metastatic Pancreatic Cancer (NCT02892305) | Duke University | 2018-05-18 |
| M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas (NCT03451773) | National Cancer Institute (NCI) | 2018-05-17 |
| Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms (NCT03435770) | Singapore General Hospital | 2018-03-01 |
| A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus (NCT03937453) | Nuvance Health | 2018-01-19 |
| POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection (NCT03400280) | St. Antonius Hospital | 2018-01-08 |
| Laser Tissue Welding - Distal Pancreatectomy Sealing Study (NCT03147768) | Laser Tissue Welding, Inc. | 2018-01-01 |
| Contrast-enhanced Diffusion-weighted MRI to Detect Liver Metastases in Patients With Pancreatic Cancer (NCT03469726) | Radboud University Medical Center | 2017-12-22 |
| CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice (NCT02900248) | CureOne | 2017-10-02 |
| Connect Your Needle to Your Phone to Increase EUS FNA Diagnostic Yield? (NCT03303352) | Carol Davila University of Medicine and Pharmacy | 2017-07-24 |
| Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) (NCT02758587) | NHS Greater Glasgow and Clyde | 2017-07-04 |
| Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis (NCT03152487) | AdventHealth | 2017-04-24 |
| Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic Cancer (NCT03199144) | Centre Francois Baclesse, Luxembourg | 2017-04-20 |
| A Pan-European Study on Minimally Invasive Versus Open Pancreatoduodenectomy in High-volume Centers (NCT03172572) | S (Sjors) Klompmaker, MD | 2017-02-01 |
| Energy Expenditure and Nutrition After Pancreatic Surgery (NCT07703813) | Evangelismos Hospital | 2017-01-10 |
| Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer (NCT03114631) | The Republican Research and Practical Center for Epidemiology and Microbiology | 2017-01-09 |
| FGF19 in Obstructive Cholestasis: "Unveil the Signal" (NCT05718349) | Nicole Hildebrand | 2017-01-01 |
| Clinico-demographic Profile of the Patient With Pancreaticobiliary Malignancy Undergoing ERCP in a Tertiary Care Center of Nepal (NCT06888401) | Kathmandu University School of Medical Sciences | 2017-01-01 |
| Comparison Between Wound Vacuum Dressing and Standard Closure to Reduce Rates of Surgical Site Infections (NCT03021668) | Johns Hopkins University | 2017-01-01 |
| The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma (NCT06553040) | Ege University | 2017-01-01 |
| Registry of Pancreatic Disease (NCT03807687) | Azienda Ospedaliera Universitaria Integrata Verona | 2016-12-01 |
| EUS Fiducial for Pancreas Surgery (NCT02863783) | University of Southern California | 2016-11-23 |
| A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals (NCT03250078) | Nuvance Health | 2016-11-01 |
| Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy (NCT02784353) | Asan Medical Center | 2016-10-04 |
| CTC Pancreatic Adenocarcinoma (NCT02335151) | University of Zurich | 2016-10-01 |
| A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations (NCT02950064) | Placon Therapeutics | 2016-09-01 |
| Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary Obstruction (NCT03054987) | AdventHealth | 2016-09-01 |
| Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors (NCT02810418) | National Cancer Institute (NCI) | 2016-08-03 |
| Fluorouracil and Oxaliplatin as First-line for Advanced Pancreatic Cancer (NCT02896803) | Instituto do Cancer do Estado de São Paulo | 2016-08-01 |
| Combined Resection vs. Separated Resection After Mobilization of Splenic Vein During Distal Pancreatectomy (NCT02871804) | Wakayama Medical University | 2016-08-01 |
| Evaluation of Killing Activity of Expanded Natural Killer Cells From Blood in Patients With Pancreatic Cancer (NCT03665571) | Asan Medical Center | 2016-07-01 |
| Contrast EUS of the Pancreas (NCT02863770) | University of Southern California | 2016-07-01 |
| Diagnostic Yield of 20-gauge Procore Needle for EUS-guided FNA Biopsy in Solid Pancreatic Lesions (NCT02920944) | Seung Bae Yoon | 2016-07-01 |
| Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region (NCT02780648) | Indiana University | 2016-05-01 |
| Different Stapler Cartridge For Pancreatic Stump Texture To Prevent Pancreatic Fistula (NCT02790333) | Yi-Ping Mou | 2016-05-01 |
| HYPAR Trial - Hydrocortisone vs. Pasireotide in Reducing Pancreatic Surgery Complications (NCT02775227) | Helsinki University Central Hospital | 2016-05-01 |
| Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer (NCT02737228) | CrystalGenomics, Inc. | 2016-03-01 |
| Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes (NCT02754180) | Peking Union Medical College Hospital | 2016-03-01 |
| Project Survival-Prospective Biomarker Discovery (NCT02781012) | Pancreatic Cancer Research Team | 2016-03-01 |
| HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma (NCT02850874) | Wake Forest University Health Sciences | 2016-02-01 |
| Dynamic Changes of Sera Immunoglobulin G4 and Interleukin-10 in the Patients of Pancreatic Cancer After Chemotherapy (NCT02654288) | Peking Union Medical College Hospital | 2016-01-01 |
| Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease (NCT07405099) | National Taiwan University Hospital | 2016-01-01 |
| Acelarin First Line Randomised Pancreatic Study (NCT03610100) | The Clatterbridge Cancer Centre NHS Foundation Trust | 2015-12-01 |
| Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 Catheter (NCT02591082) | RenovoRx | 2015-12-01 |
| Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma (NCT02977702) | Institut de Cancérologie de Lorraine | 2015-12-01 |
| Pancreatic Cancer Screening of High-Risk Individuals in Arkansas (NCT02309632) | University of Arkansas | 2015-11-01 |
| A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Route Clinical Practice Treating Pancreatic Cancer (NCT02670746) | Celgene | 2015-10-01 |
| Second-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic Cancer (NCT02558868) | Zhejiang University | 2015-09-01 |
| Rapid On-Site Evaluation (ROSE) by Endosonographer: for Whom, When and by Whom? (NCT04002778) | Universidade Federal do Rio de Janeiro | 2015-08-01 |
| Laparotomy, Laparoscopy, da Vinci System (NCT07034495) | National Chung Hsing University | 2015-07-01 |